These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 478161)

  • 1. A month-by-month long-term study on carbamazepine:clinical, EEG and pharmacological evaluation.
    Monaco F; Riccio A; Fantini M; Baruzzi A; Morselli PL
    J Int Med Res; 1979; 7(2):152-7. PubMed ID: 478161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further observations on carbamazepine plasma levels in epileptic patients. Relationships with therapeutic and side effects.
    Monaco F; Riccio A; Benna P; Covacich A; Durelli L; Fantini M; Furlan PM; Gilli M; Mutani R; Troni W; Gerna M; Morselli PL
    Neurology; 1976 Oct; 26(10):936-73. PubMed ID: 986584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlations between electroencephalographic tracings, epileptic seizures and blood levels of the drug in patients in long-term treatment with carbamezepine].
    Monaco F; Riccio A; Morselli PL; Mutani R
    Riv Neurol; 1978; 48(5):588-93. PubMed ID: 746313
    [No Abstract]   [Full Text] [Related]  

  • 4. Carbamazepine therapy and long-term prognosis in epilepsy of childhood.
    Okuno T; Ito M; Nakano S; Hattori H; Fujii T; Go T; Mikawa H
    Epilepsia; 1989; 30(1):57-61. PubMed ID: 2912717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbamazepine monotherapy in epileptic out-patients.
    Andersen EB; Philbert A; Klee JG
    Acta Neurol Scand Suppl; 1983; 94():29-34. PubMed ID: 6410672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EEG changes in patients during the introduction of carbamazepine.
    Besser R; Hornung K; Theisohn M; Rothacher G; Krämer G
    Electroencephalogr Clin Neurophysiol; 1992 Jul; 83(1):19-23. PubMed ID: 1376662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once daily dosage versus divided daily doses of carbamazepine therapy in epileptic patients: a pilot study.
    Ghose K; Dawson M; Fry DE; Christofides JA
    Pharmatherapeutica; 1981; 3(1):71-8. PubMed ID: 7033994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbamazepine does not affect short-latency somatosensory evoked potentials: a longitudinal study in newly diagnosed epilepsy.
    Carenini L; Bottacchi E; Camerlingo M; D'Alessandro G; Mamoli A
    Epilepsia; 1988; 29(2):145-8. PubMed ID: 3349965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbamazepine and its epoxide: an open study of efficacy and side effects after carbamazepine dose increment in refractory partial epilepsy.
    Semah F; Gimenez F; Longer E; Laplane D; Thuillier A; Baulac M
    Ther Drug Monit; 1994 Dec; 16(6):537-40. PubMed ID: 7878690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbamazepine and the electroencephalogram of epileptics: a double blind study in comparison to phenytoin.
    Wilkus RJ; Dodrill CB; Troupin AS
    Epilepsia; 1978 Jun; 19(3):283-91. PubMed ID: 354922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment with carbamazepine of epilepsy with behavioral trouble in mentally retarded children in a medicopedagogic institution (author's transl)].
    d'Hollander L
    Acta Psychiatr Belg; 1979; 79(5):557-69. PubMed ID: 121194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbamazepine-10,11-epoxide in epilepsy. A pilot study.
    Tomson T; Almkvist O; Nilsson BY; Svensson JO; Bertilsson L
    Arch Neurol; 1990 Aug; 47(8):888-92. PubMed ID: 2375696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment termination in children with idiopathic generalized epilepsy and cryptogenic focal epilepsy].
    Szwed-Białozyt B; Marszał E
    Przegl Lek; 2003; 60 Suppl 1():5-9. PubMed ID: 12945154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monotherapy with carbamazepine in childhood epilepsies].
    Dulac O; Bouguerra L; Rey E; de Lauture D; Arthuis M
    Arch Fr Pediatr; 1983 May; 40(5):415-9. PubMed ID: 6411042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacology of chewable versus regular carbamazepine in chronically treated children with epilepsy.
    Camfield P; Hwang P; Camfield C; Fraser A; Soldin S; al-Quadah AK
    Can J Neurol Sci; 1992 May; 19(2):204-7. PubMed ID: 1623447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative open trial of carbamazepine and slow-release carbamazepine in epilepsy in adults].
    Remy C
    Presse Med; 1990 Mar; 19(11):511-3. PubMed ID: 2138749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breakthrough seizures with generic carbamazepine: a consequence of poorer bioavailability?
    Hartley R; Aleksandrowicz J; Ng PC; McLain B; Bowmer CJ; Forsythe WI
    Br J Clin Pract; 1990 Jul; 44(7):270-3. PubMed ID: 2206824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steady-state carbamazepine plasma concentration-dose ratios in epileptic patients.
    Sánchez A; Durán JA; Serrano JS
    Clin Pharmacokinet; 1986; 11(5):411-4. PubMed ID: 3780114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of newly diagnosed epileptic crises. A French experience].
    Groupe CAROLE (Coordination Active du Réseau Observatoire Longitudinal de l'Epilepsie)
    Rev Neurol (Paris); 2001 Dec; 157(12):1500-12. PubMed ID: 11924446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of the simultaneous determination of carbamazepine and its 10,11-epoxide from plasma and human erythrocytes.
    Pynnönen S; Yrjänä T
    Int J Clin Pharmacol Biopharm; 1977 May; 15(5):222-6. PubMed ID: 873665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.